Table 3.

Liner regression analysis for the relationship of log-transformed PSG-based sleep parameters with log-transformed plasma aldosterone concentration in men participants with hypertension without interfering agents (B, 95%CI, p).

Log plasma aldosterone concentration	Crude model	Adjusted model
Log apnea hypopnea index	0.01 (−0.01,0.04), 0.146	0.01 (−0.03,0.05), 0.738
Log apnea index	0.02 (0.01,0.04), 0.049	0.04 (0.01,0.07), 0.022
Log hypopnea index	0.01 (−0.02,0.03), 0.757	−0.04 (−0.08,0.01), 0.129
Log lowest desaturation of oxygen	−0.17 (−0.35,0.01), 0.067	−0.39 (−0.78,−0.01), 0.044
Log mean oxygen saturation	−0.12 (−0.60,0.36), 0.638	0.12 (−0.48,0.86), 0.582
Log time spent with oxygen saturation <90%	0.01 (−0.01,0.02), 0.540	0.02 (−0.01,0.05), 0.083
Log oxygen desaturation index ≥3%	0.00 (−0.03,0.03), 0.994	−0.01 (−0.05,0.02), 0.454
Log oxygen desaturation index ≥4%	0.01 (−0.02,0.03), 0.739	−0.01 (−0.03,0.02), 0.642
Log maximum duration of hypoventilation	0.03 (−0.02,0.09), 0.245	0.04 (−0.07,0.15), 0.509
Log average duration of hypoventilation	0.03 (−0.05,0.12), 0.472	0.04 (−0.13,0.21), 0.653
Log wake after sleep onset	−0.01 (−0.04,0.02), 0.642	0.02 (−0.03,0.08), 0.410
Log arousal time	0.01 (−0.03,0.056), 0.707	0.02 (−0.05,0.10), 0.575

Adjusted for log-transformed age, body mass index, systolic and diastolic blood pressure, alanine aminotransferase, plasma renin activity, serum potassium, and 24-h urinary potassium